Paloma Partners Management CO Bausch Health Companies Inc. Call Options Transaction History

Paloma Partners Management CO

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.65 Million - $5.51 Million	-233,100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $1.01 Million - $1.3 Million	-46,700 Reduced 16.69%	233,100 $5.33 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $6.44 Million - $8.12 Million	279,800 New	279,800 $7.73 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $216,953 - $334,313	-16,300 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $578,908 - $1.35 Million	-44,600 Reduced 73.23%	16,300 $252,000
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $324,908 - $548,508	17,200 Added 39.36%	60,900 $1.82 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $432,216 - $531,162	20,700 Added 90.0%	43,700 $955,000
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $227,772 - $293,595	-11,100 Reduced 32.55%	23,000 $580,000
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $93,058 - $120,934	4,600 Added 15.59%	34,100 $842,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $520,380 - $835,440	29,500 New	29,500 $545,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.